
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xml:lang="en-US"
               >
      <channel>
        <title>Latest articles from ONA</title>
        <link>http://feeds.feedburner.com/onahome</link>
        <description>Latest articles from ONA</description>
        
          <itunes:author><![CDATA[ONA]]></itunes:author>
        <itunes:subtitle>Home</itunes:subtitle>
        <itunes:summary><![CDATA[We offer clinical cancer updates, treatment guidance, and research news to the oncology nursing community. Visit us often for drug therapy testing results, patient care information and more. Download our FREE app today.]]></itunes:summary>
        <itunes:owner>
            <itunes:name>Home</itunes:name>
            <itunes:email>Admin@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="Business">
            <itunes:category text="Business News" /> 
        </itunes:category> 
        <itunes:image href='https://media.oncologynurseadvisor.com/images/2010/06/01/onalogo-mobile_103794.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
          
          <atom:link href="http://feeds.feedburner.com/onahome" rel="self" type="application/rss+xml" />
  
        <item>
          
          <title>Primary Histologic Subtype an Independent Predictor of Survival in Melanoma</title>
            
            
            <description>A comparison study of the tumor molecular profiles of NM and SSM sought to explain the distinctly different prognoses among patients with either of these 2 histologic subtypes.</description>
            
            <link>https://www.oncologynurseadvisor.com/primary-histologic-subtype-predictive-of-survival-in-melanoma/article/836200/</link>
            <pubDate>Tue, 26 Feb 2019 15:00:00 GMT</pubDate>
            
          <itunes:summary>A comparison study of the tumor molecular profiles of NM and SSM sought to explain the distinctly different prognoses among patients with either of these 2 histologic subtypes.</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/primary-histologic-subtype-predictive-of-survival-in-melanoma/article/836200/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Adverse Events in Randomized Clinical Trials for Targeted Therapies High in Placebo Groups</title>
            
            
            <description>Researchers conducted a meta-analysis to determine the incidence of adverse events among patients assigned to placebo-receiving groups in randomized clinical trials.</description>
            
            <link>https://www.oncologynurseadvisor.com/aes-in-rcts-for-targeted-therapies-high-in-placebo-groups/article/835905/</link>
            <pubDate>Mon, 25 Feb 2019 16:00:00 GMT</pubDate>
            
          <itunes:summary>Researchers conducted a meta-analysis to determine the incidence of adverse events among patients assigned to placebo-receiving groups in randomized clinical trials.</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/aes-in-rcts-for-targeted-therapies-high-in-placebo-groups/article/835905/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Internet-Based CBT Program Improves Management of Menopausal Symptoms in Breast Cancer Survivors</title>
            
            
            <description>A randomized study sought to determine if an Internet-based cognitive behavioral therapy program focused on managing treatment-induced menopausal symptoms has the potential to help breast cancer survivors adhere to long-term endocrine therapy.</description>
            
            <link>https://www.oncologynurseadvisor.com/icbt-improves-treatment-induced-symptoms-in-breast-cancer-survivors/article/835901/</link>
            <pubDate>Mon, 25 Feb 2019 15:00:00 GMT</pubDate>
            
          <itunes:summary>A randomized study sought to determine if an Internet-based cognitive behavioral therapy program focused on managing treatment-induced menopausal symptoms has the potential to help breast cancer survivors adhere to long-term endocrine therapy.</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/icbt-improves-treatment-induced-symptoms-in-breast-cancer-survivors/article/835901/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Negative Body Image Persists for Women Undergoing Risk-Reduction Mastectomy </title>
            
            
            <description>A prospective study sought to measure levels of satisfaction at 1 year and at long term (6 to 20 years) after prophylactic RRD in women with no cancer diagnosis (bilateral mastectomy) and in those with a breast cancer diagnosis (contralateral mastectomy).</description>
            
            <link>https://www.oncologynurseadvisor.com/persistent-negative-body-image-after-rrd-mastectomy/article/835522/</link>
            <pubDate>Fri, 22 Feb 2019 15:00:00 GMT</pubDate>
            
          <itunes:summary>A prospective study sought to measure levels of satisfaction at 1 year and at long term (6 to 20 years) after prophylactic RRD in women with no cancer diagnosis (bilateral mastectomy) and in those with a breast cancer diagnosis (contralateral mastectomy).</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/persistent-negative-body-image-after-rrd-mastectomy/article/835522/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Hypofractionated Radiotherapy for Prostate Cancer: The New ASTRO/ASCO/AUA Guideline</title>
            
            
            <description>New joint guideline from ASTRO, ASCO, and AUA offers an alternative to conventional radiation regimens for those patients who opt for treatment instead of active surveillance or surgery.</description>
            
            <link>https://www.oncologynurseadvisor.com/astro-asco-aua-guideline-for-hypofractionated-rt-for-prostate-cancer/article/835345/</link>
            <pubDate>Thu, 21 Feb 2019 16:00:00 GMT</pubDate>
            
          <itunes:summary>New joint guideline from ASTRO, ASCO, and AUA offers an alternative to conventional radiation regimens for those patients who opt for treatment instead of active surveillance or surgery.</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/astro-asco-aua-guideline-for-hypofractionated-rt-for-prostate-cancer/article/835345/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Risk of Hospitalization Remains High for Survivors of Childhood Leukemia</title>
            
            
            <description>A retrospective study using a cohort of the ALiCCS Study sought to determine hospitalization risks among survivors of leukemia during childhood 20 years after diagnosis.</description>
            
            <link>https://www.oncologynurseadvisor.com/hospitalization-risks-remain-high-for-survivors-of-childhood-leukemia/article/835344/</link>
            <pubDate>Thu, 21 Feb 2019 14:30:00 GMT</pubDate>
            
          <itunes:summary>A retrospective study using a cohort of the ALiCCS Study sought to determine hospitalization risks among survivors of leukemia during childhood 20 years after diagnosis.</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/hospitalization-risks-remain-high-for-survivors-of-childhood-leukemia/article/835344/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Sequence of Immunotherapy, Targeted Therapy, Radiation Therapy Influences Overall Survival in Melanoma Brain Metastases</title>
            
            
            <description>Retrospective study investigated the effect sequence has on overall survival in patients with melanoma brain metastases treated with a combination of SRS, WBRT, immunotherapy, or targeted therapy.</description>
            
            <link>https://www.oncologynurseadvisor.com/sequence-of-therapies-for-melanoma-brain-metastases-influences-os/article/835234/</link>
            <pubDate>Wed, 20 Feb 2019 19:00:00 GMT</pubDate>
            
          <itunes:summary>Retrospective study investigated the effect sequence has on overall survival in patients with melanoma brain metastases treated with a combination of SRS, WBRT, immunotherapy, or targeted therapy.</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/sequence-of-therapies-for-melanoma-brain-metastases-influences-os/article/835234/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Survey Demonstrates Implicit Bias Toward Cervical Cancer Diagnoses Among Nurses, Women</title>
            
            
            <description>Survey sought to assess the relative implicit biases of gynecologic healthcare providers regarding women with diagnoses of cervical vs ovarian cancer.</description>
            
            <link>https://www.oncologynurseadvisor.com/implicit-bias-among-nurses-women-toward-cervical-cancer-diagnoses/article/834953/</link>
            <pubDate>Tue, 19 Feb 2019 20:00:00 GMT</pubDate>
            
          <itunes:summary>Survey sought to assess the relative implicit biases of gynecologic healthcare providers regarding women with diagnoses of cervical vs ovarian cancer.</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/implicit-bias-among-nurses-women-toward-cervical-cancer-diagnoses/article/834953/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Sharing Personal Contact Information With Patients</title>
            
            
            <description>Some of my oncology nurse colleagues give patients their personal cell phone numbers. Sometimes I feel like I&apos;m the odd one for not giving my number when patients ask if they can text me. Am I behind the times?</description>
            
            <link>https://www.oncologynurseadvisor.com/sharing-personal-contact-information-with-patients/article/834782/</link>
            <pubDate>Tue, 19 Feb 2019 16:00:00 GMT</pubDate>
            
          <itunes:summary>Some of my oncology nurse colleagues give patients their personal cell phone numbers. Sometimes I feel like I&apos;m the odd one for not giving my number when patients ask if they can text me. Am I behind the times?</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/sharing-personal-contact-information-with-patients/article/834782/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Nurse-Led vs Oncologist-Led Breast Cancer Follow-up Program: Early Feasibility Results of an Ongoing Study</title>
            
            
            <description>Early feasibility results are presented for a trial that evaluates whether standard-of-care follow-up for women with early-stage breast cancer can be replaced by a nurse-led intervention focusing on patient self-management.</description>
            
            <link>https://www.oncologynurseadvisor.com/early-feasibility-results-of-an-ongoing-study-of-brca-follow-up-programs/article/834653/</link>
            <pubDate>Mon, 18 Feb 2019 15:00:00 GMT</pubDate>
            
          <itunes:summary>Early feasibility results are presented for a trial that evaluates whether standard-of-care follow-up for women with early-stage breast cancer can be replaced by a nurse-led intervention focusing on patient self-management.</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/early-feasibility-results-of-an-ongoing-study-of-brca-follow-up-programs/article/834653/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Survey Demonstrates Relationship Between Symptom Burden, Medical Disability Leave Among Myeloproliferative Neoplasms </title>
            
            
            <description>A survey-based study investigated the relationship between symptom burden and incidence of medical disability leave among patients with MPNs.</description>
            
            <link>https://www.oncologynurseadvisor.com/survey-demonstrates-symptom-burden-related-to-mdl-among-mpns/article/834450/</link>
            <pubDate>Fri, 15 Feb 2019 13:30:00 GMT</pubDate>
            
          <itunes:summary>A survey-based study investigated the relationship between symptom burden and incidence of medical disability leave among patients with MPNs.</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/survey-demonstrates-symptom-burden-related-to-mdl-among-mpns/article/834450/</guid>
               
                                
        </item>
  
        <item>
          
          <title>A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma</title>
            
            
            <description>Older age is associated with worse prognosis in patients with early-stage Burkitt lymphoma, according to study authors.</description>
            
            <link>https://www.oncologynurseadvisor.com/review-clinical-outcomes-patients-early-stage-burkitt-lymphoma/article/834458/</link>
            <pubDate>Thu, 14 Feb 2019 21:00:00 GMT</pubDate>
            
          <itunes:summary>Older age is associated with worse prognosis in patients with early-stage Burkitt lymphoma, according to study authors.</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/review-clinical-outcomes-patients-early-stage-burkitt-lymphoma/article/834458/</guid>
               
                                
        </item>
  
        <item>
          
          <title>NIH Establishes Educational Program on Genomics, Genetics for Oncology Nurses </title>
            
            
            <description>NIH sought to bridge the gap in oncology nurse training in genomics and genetics to improve patient education and assessment of related risk factors.</description>
            
            <link>https://www.oncologynurseadvisor.com/nursing-program-on-genomics-genetics-developed-by-nih/article/833889/</link>
            <pubDate>Wed, 13 Feb 2019 15:30:00 GMT</pubDate>
            
          <itunes:summary>NIH sought to bridge the gap in oncology nurse training in genomics and genetics to improve patient education and assessment of related risk factors.</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/nursing-program-on-genomics-genetics-developed-by-nih/article/833889/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Significance of Amino Acid Solution With Lutetium Lu 177 Dotatate</title>
            
            
            <description>What is the importance of the amino acid solution given before lutetium Lu 177 dotatate? Which is the difference between a specially compounded solution and a standard solution?</description>
            
            <link>https://www.oncologynurseadvisor.com/amino-acid-solution-with-lutathera/article/832854/</link>
            <pubDate>Thu, 07 Feb 2019 21:00:00 GMT</pubDate>
            
          <itunes:summary>What is the importance of the amino acid solution given before lutetium Lu 177 dotatate? Which is the difference between a specially compounded solution and a standard solution?</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/amino-acid-solution-with-lutathera/article/832854/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Secondhand Smoke and Cancer (Fact Sheet) </title>
            
            
            <description>This fact sheet reviews secondhand smoke composition, links between secondhand smoke and cancer, and secondhand smoke emitted from electronic cigarettes.</description>
            
            <link>https://www.oncologynurseadvisor.com/secondhand-smoke-and-cancer/article/830709/</link>
            <pubDate>Wed, 06 Feb 2019 14:00:00 GMT</pubDate>
            
          <itunes:summary>This fact sheet reviews secondhand smoke composition, links between secondhand smoke and cancer, and secondhand smoke emitted from electronic cigarettes.</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/secondhand-smoke-and-cancer/article/830709/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Substitute for Lidocaine</title>
            
            
            <description>What options are available to minimize the pain associated with goserelin injections?</description>
            
            <link>https://www.oncologynurseadvisor.com/substitute-for-lidocaine/article/829996/</link>
            <pubDate>Mon, 28 Jan 2019 19:30:00 GMT</pubDate>
            
          <itunes:summary>What options are available to minimize the pain associated with goserelin injections?</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/substitute-for-lidocaine/article/829996/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Hormone Therapy for Breast Cancer (Fact Sheet)</title>
            
            
            <description>This fact sheet reviews the use of hormone therapy in breast cancer therapy and possible side effects of treatment.</description>
            
            <link>https://www.oncologynurseadvisor.com/hormone-therapy-for-breast-cancer-fact-sheet/article/825455/</link>
            <pubDate>Thu, 10 Jan 2019 21:00:00 GMT</pubDate>
            
          <itunes:summary>This fact sheet reviews the use of hormone therapy in breast cancer therapy and possible side effects of treatment.</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/hormone-therapy-for-breast-cancer-fact-sheet/article/825455/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial</title>
            
            
            <description>The management of acute, radiotherapy-related nociceptive and neuropathic pain in patients undergoing radiotherapy for head and neck cancers remains an ongoing challenge. Pregabalin, an anticonvulsant drug, has been shown to be efficacious in treating various chronic neuropathic pain conditions. In this randomized controlled trial, investigators randomized 128 patients treated with radiotherapy for head and neck []</description>
            
            <link>https://www.oncologynurseadvisor.com/quick-take-effect-of-pregabalin-on-radiotherapy-related-neuropathic-pain-in-patients-with-head-and-neck-cancer-a-randomized-controlled-trial/article/817943/</link>
            <pubDate>Wed, 12 Dec 2018 17:00:00 GMT</pubDate>
            
          <itunes:summary>The management of acute, radiotherapy-related nociceptive and neuropathic pain in patients undergoing radiotherapy for head and neck cancers remains an ongoing challenge. Pregabalin, an anticonvulsant drug, has been shown to be efficacious in treating various chronic neuropathic pain conditions. In this randomized controlled trial, investigators randomized 128 patients treated with radiotherapy for head and neck []</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/quick-take-effect-of-pregabalin-on-radiotherapy-related-neuropathic-pain-in-patients-with-head-and-neck-cancer-a-randomized-controlled-trial/article/817943/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Quick Take: Risk of Suicide After Cancer Diagnosis in England</title>
            
            
            <description>The receipt of a cancer diagnosis can be devastating, with important implications for a patient&apos;s mental health and well-being. Some evidence has suggested that cancer diagnosis may contribute to an increased risk of suicide in this patient population; however, variation in risk by various patient characteristics has not been well-studied. In this cohort study, investigators []</description>
            
            <link>https://www.oncologynurseadvisor.com/quick-take-risk-of-suicide-after-cancer-diagnosis-in-england/article/818904/</link>
            <pubDate>Mon, 10 Dec 2018 17:00:00 GMT</pubDate>
            
          <itunes:summary>The receipt of a cancer diagnosis can be devastating, with important implications for a patient&apos;s mental health and well-being. Some evidence has suggested that cancer diagnosis may contribute to an increased risk of suicide in this patient population; however, variation in risk by various patient characteristics has not been well-studied. In this cohort study, investigators []</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/quick-take-risk-of-suicide-after-cancer-diagnosis-in-england/article/818904/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Quick Take: Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality</title>
            
            
            <description>Several treatment regimens are available for prostate cancer with a Gleason score of 9 or 10. These include radical prostatectomy (RP) with adjuvant external beam radiation therapy (EBRT), androgen deprivation therapy (ADT), or both (MaxRP), as well as a regimen without surgery that includes EBRT, ADT, and brachytherapy (MaxRT). In this cohort study, MaxRP was []</description>
            
            <link>https://www.oncologynurseadvisor.com/quick-take-surgery-vs-radiotherapy-in-the-management-of-biopsy-gleason-score-9-10-prostate-cancer-and-the-risk-of-mortality/article/816439/</link>
            <pubDate>Mon, 03 Dec 2018 17:00:00 GMT</pubDate>
            
          <itunes:summary>Several treatment regimens are available for prostate cancer with a Gleason score of 9 or 10. These include radical prostatectomy (RP) with adjuvant external beam radiation therapy (EBRT), androgen deprivation therapy (ADT), or both (MaxRP), as well as a regimen without surgery that includes EBRT, ADT, and brachytherapy (MaxRT). In this cohort study, MaxRP was []</itunes:summary>
          <itunes:author><![CDATA[ONA]]></itunes:author>
            
            
            
            <guid>https://www.oncologynurseadvisor.com/quick-take-surgery-vs-radiotherapy-in-the-management-of-biopsy-gleason-score-9-10-prostate-cancer-and-the-risk-of-mortality/article/816439/</guid>
               
                                
        </item>
  
      </channel>
    </rss>  
  